Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics
- PMID: 1675890
- DOI: 10.1016/0006-3223(91)90094-3
Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics
Abstract
Event-related potentials (ERPs) and electrodermal activity were studied in 14 medicated schizophrenics, 17 unmedicated schizophrenics, and 23 age- and education-matched controls. Subjects were run in three auditory stimulus paradigms differing from the usual ERP paradigms in having interstimulus intervals greater than 12 sec to permit measurement of the longer latency skin conductance response (SCR). In every paradigm medicated but not unmedicated schizophrenics had smaller N120 amplitudes and fewer SCRs than controls. In addition, medicated schizophrenics showed reduced P200 amplitude and latency, longer P320 latency, and reduced skin conductance levels in certain paradigms. These effects cannot easily be attributed to different mental states of medicated and unmedicated patients, since their Brief Psychiatric Rating Scale scores were almost the same. It is more probable that antipsychotic and antiparkinsonian drugs reduced electrodermal activity through anticholinergic mechanisms and that the antipsychotic drugs attenuated N120 through other biological mechanisms.
Similar articles
-
ERPs in schizophrenia: effects of antipsychotic medication.Biol Psychiatry. 1994 Aug 1;36(3):153-70. doi: 10.1016/0006-3223(94)91221-1. Biol Psychiatry. 1994. PMID: 7948453 Clinical Trial.
-
Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses.Schizophr Res. 2002 May 1;55(1-2):147-58. doi: 10.1016/s0920-9964(01)00250-x. Schizophr Res. 2002. PMID: 11955974
-
Measurement of maximum variability within event related potentials in schizophrenia.Psychiatry Res. 1991 Oct;39(1):33-44. doi: 10.1016/0165-1781(91)90006-b. Psychiatry Res. 1991. PMID: 1685249
-
Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.Biol Psychiatry. 1996 Jul 1;40(1):19-27. doi: 10.1016/0006-3223(95)00351-7. Biol Psychiatry. 1996. PMID: 8780851
-
Reduced auditory evoked potential component N100 in schizophrenia--a critical review.Psychiatry Res. 2008 Dec 15;161(3):259-74. doi: 10.1016/j.psychres.2008.03.017. Epub 2008 Oct 15. Psychiatry Res. 2008. PMID: 18926573 Review.
Cited by
-
Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.Biol Psychiatry. 2020 Aug 15;88(4):294-303. doi: 10.1016/j.biopsych.2020.04.002. Epub 2020 Apr 14. Biol Psychiatry. 2020. PMID: 32507388 Free PMC article. Review.
-
Anticipating the future: automatic prediction failures in schizophrenia.Int J Psychophysiol. 2012 Feb;83(2):232-9. doi: 10.1016/j.ijpsycho.2011.09.004. Epub 2011 Sep 28. Int J Psychophysiol. 2012. PMID: 21959054 Free PMC article. Review.
-
A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.J Psychiatry Neurosci. 2018 May;43(3):182-193. doi: 10.1503/jpn.170093. J Psychiatry Neurosci. 2018. PMID: 29688874 Free PMC article.
-
Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia.Neuroimage Clin. 2016 Aug 10;12:429-41. doi: 10.1016/j.nicl.2016.08.009. eCollection 2016. Neuroimage Clin. 2016. PMID: 27622140 Free PMC article.
-
Neurophysiological Models in Individuals at Clinical High Risk for Psychosis: Using Translational EEG Paradigms to Forecast Psychosis Risk and Resilience.Adv Neurobiol. 2024;40:385-410. doi: 10.1007/978-3-031-69491-2_14. Adv Neurobiol. 2024. PMID: 39562452 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical